Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 50 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Docteur Roobaert J.M. from Enghien, company number BE0440363964, closed financial year 2025 with a result of € 64,440 after tax. For that financial year Docteur Roobaert J.M. recorded a gross margin of € 101,540 and equity of € 364,633. Compared with financial year 2024, the result moved from € 256 to € 64,440. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 17, 2026.
€ 364,633
▼ 27% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 64,440
▲ € 64,183 vs 2024
Profit after tax over the fiscal year.
€ 79,992
▲ 1% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 200,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 4,326
▲ 151% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 31,973 | € 29,734 | € 29,232 | € 101,540 | ▲ 247% |
| Profit after taxes | € 3,497 | € 25,171 | € 256 | € 64,440 | ▲ € 64,183 |
| Equity | € 474,766 | € 499,937 | € 500,193 | € 364,633 | ▼ 27% |
| Total debts | € 902,934 | € 612,478 | € 696,921 | € 436,253 | ▼ 37% |
| Cash | € 71,859 | € 61,398 | € 78,930 | € 79,992 | ▲ 1% |
| Land & buildings | € 81,325 | € 79,392 | € 79,255 | - | |
| Retained profit | € 462,163 | € 487,335 | € 487,591 | € 352,031 | ▼ 28% |
| Dividend | € 320,000 | € 0 | € 0 | € 200,000 | |
| Balance sheet total | € 1,377,700 | € 1,112,415 | € 1,197,114 | € 800,886 | ▼ 33% |
Key figures of Docteur Roobaert J.M., fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to Docteur Roobaert J.M.?
What happened at Docteur Roobaert J.M. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 64,440 (▲ € 64,183 vs 2024). Source: NBB ↗
- JEAN-MARIE ROOBAERT became a director. NBB
- New establishment in Enghien. KBO
- Start of the company according to the CBE. KBO
In short
From € 3,497 profit in 2022 to € 64,440 profit in 2025.
Paid € 42,503 in corporate taxes since 2022.
Best year ever: 2025, with € 64,440 profit.
Paid out € 520,000 in dividends to the owners in total.
A new publication or filing at Docteur Roobaert J.M.? We notify you, reason included.
Follow Docteur Roobaert J.M.Databakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of OCULOMED comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Docteur Roobaert J.M.Behind Docteur Roobaert J.M. is JEAN-MARIE ROOBAERT. The shares are held by OCULOMED (100%).
Directors
According to the 2025 annual accounts
JEAN-MARIE ROOBAERT
Director
since 1990
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Aatsesteenweg 20
7850 Enghien
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0440.363.964
- VAT number
- BE 0440.363.964
- Registered office
- Aatsesteenweg 20, 7850 Enghien
- Names & denominations
- Docteur Roobaert J.M.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 March 1990
- Peppol
- Not registered